Licensing Trends By Clinical Phase

01 Jan 2003

We revisit a chart from 1997 examining deal volume by clinical phase to highlight the changing landscape of late stage licensing.

Back in September 1997, IN VIVO published an article with a chart sorting deals signed by clinical phase. At the time we noted the relative scarcity of clinical stage deals compared to discovery, and on the other end, market stage deals (see"Biotech By The Numbers," IN VIVO, Sep. 1997, Exhibit 9) Also see "Biotech Deals by the Numbers" - In Vivo, 1 September, 1997..

In Exhibit 1 below, we revisit that chart--this time breaking out deals signed in the five-year periods 1993 to 1997...